EG639025 inhibitors are a class of chemical compounds characterized by their ability to inhibit a specific molecular target associated with the modulation of cellular signaling pathways. These inhibitors often possess unique structural motifs that enable high specificity and potency in binding to their target, typically a protein or enzyme involved in key regulatory functions within the cell. By interacting with their target's active or allosteric sites, EG639025 inhibitors can alter the normal function of the protein, either blocking its enzymatic activity or preventing protein-protein interactions critical to downstream signaling events. The molecular scaffold of these inhibitors is often designed to enhance selectivity and binding affinity, which can involve optimizing hydrophobic interactions, hydrogen bonding, and electrostatic complementarity between the inhibitor and the target site. This specificity is vital for their function as it allows for minimal off-target effects and a clearer understanding of their molecular mechanisms within biochemical pathways.
The structural design of EG639025 inhibitors typically includes a core chemical framework that is modified to enhance cell permeability, metabolic stability, and binding characteristics. These modifications can include the addition of functional groups to increase solubility, improve cellular uptake, or reduce metabolic degradation. Additionally, the physicochemical properties of these inhibitors, such as their molecular weight, polar surface area, and lipophilicity, are carefully balanced to optimize their ability to effectively reach and interact with their intended molecular targets. The study of these inhibitors provides valuable insights into the regulation of cellular signaling and can serve as critical tools for elucidating the biological roles of the targeted pathways in various cellular contexts. This understanding is particularly important in the study of cellular processes such as signal transduction, proliferation, and apoptosis, allowing for a deeper exploration of the biochemical and structural basis of protein function and interaction networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $47.00 $156.00 $171.00 $525.00 $941.00 | 4 | |
An antiandrogen that can modulate androgen receptor activity, potentially affecting Pate12 regulation. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
A 5-alpha reductase inhibitor that can decrease dihydrotestosterone levels, possibly affecting Pate12 expression. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
Another antiandrogen that can alter androgen receptor signaling, potentially affecting Pate12 activity. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
An antifungal that can inhibit steroid synthesis, potentially affecting hormone-regulated proteins like Pate12. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
A more potent antiandrogen that can affect androgen receptor activity and potentially Pate12 expression. | ||||||
Apalutamide | 956104-40-8 | sc-507442 | 5 mg | $290.00 | ||
An androgen receptor antagonist that can disrupt androgen signaling, potentially influencing Pate12. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
A steroid that acts as an androgen antagonist, which can modulate Pate12 through hormonal pathways. | ||||||
Dutasteride | 164656-23-9 | sc-207600 | 10 mg | $167.00 | 2 | |
A dual 5-alpha reductase inhibitor, which can lead to reduced dihydrotestosterone and potentially affect Pate12 expression. | ||||||
Abiraterone Acetate | 154229-18-2 | sc-207240 | 5 mg | $231.00 | 1 | |
An inhibitor of androgen biosynthesis that may impact Pate12 expression by reducing androgen levels. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
An aromatase inhibitor that can lower estrogen levels, indirectly affecting Pate12 if it is regulated by estrogen. | ||||||